Cart
sales@molnova.com
Home - Products - Others - Other Targets - Trofosfamide

Trofosfamide

CAS No. 22089-22-1

Trofosfamide( —— )

Catalog No. M26852 CAS No. 22089-22-1

Trofosfamide is a derivative of oxazaphosphorine with antineoplastic potency.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 Get Quote
10MG 59 Get Quote
25MG 97 Get Quote
50MG 149 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Trofosfamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Trofosfamide is a derivative of oxazaphosphorine with antineoplastic potency.
  • Description
    Trofosfamide is a derivative of oxazaphosphorine with antineoplastic potency.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22089-22-1
  • Formula Weight
    323.58
  • Molecular Formula
    C9H18Cl3N2O2P
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (309.04 mM)
  • SMILES
    ClCCN(CCCl)P1(=O)OCCCN1CCCl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oftedal L, et al. Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid. Sci Rep. 2020;10(1):22098. Published 2020 Dec 16.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Stictic Acid

    Stictic Acid (Scopularic acid) is isolated from a Sumatran lichen Stereocaulon montagneanum and inhibits the growth of HT-29 human colon adenocarcinoma cells with an IC50 of 29.29 μg/ml.

  • Sisunatovir HCl

    Sisunatovir HCl is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses in vitro.

  • IPSU

    IPSU is an antagonist of OX2 receptor. IPSU Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors.

Sign In Join Free